期刊文献+

活血降脂保肝汤对NAFLD大鼠肝组织MTP mRNA及蛋白表达的影响 被引量:5

Effect of Huoxue Jiangzhi Baogan Decoction on MTP mRNA and Protein Expressions in Hepatocytes of NAFLD Rats
原文传递
导出
摘要 目的:观察活血降脂保肝汤(HJBD)对非酒精性脂肪性肝病(NAFLD)大鼠肝组织微粒体甘油三脂转运蛋白(MTP)mRNA及蛋白表达的影响,探讨其防治NAFLD可能的作用机制。方法:取健康雄性SD大鼠60只随机分为6组,正常组,模型组,HJBD低、中、高剂量组(6.48,13.68,27.36 g·kg-1)及强肝片组(0.067 g·kg-1)。除正常组外,其余各组给予高脂饮食8周后,用低、中、高剂量HJBD及强肝片进行干预,连续ig 10周。采集空腹血分离血清检测各组大鼠血脂情况,取肝组织行苏木素-伊红(HE)观察大鼠肝组织病理变化,逆转录-聚合酶链式反应(RT-PCR)检测MTP mRNA及蛋白的表达情况。结果:免疫组化及RT-PCR检测结果显示,与正常组比较,模型组MTP表达水平降低,差异有统计学意义(P<0.01);与模型组比较,HJBD各剂量组及强肝片组MTP表达均升高,差异有统计学意义(P<0.01,P<0.05),以高剂量组升高最明显;血脂紊乱及肝脂肪变性也较模型组有不同程度改善。结论:HJBD对高脂饮食诱导的NAFLD大鼠有较好的治疗作用,推测MTP可能是HJBD抗NAFLD的有效作用靶点。 Objective: To observe the effects of Huoxue Jiangzhi Baogan decoction( HJBD) on the mRNA and protein expression levels of microsomal triglyceride transfer protein( MTP) in liver tissues of rats with non-alcoholic fatty liver disease( NAFLD),and explore its possible mechanisms of prevention and treatment for NAFLD. Method: Totally 60 healthy male SD rats were randomly divided into 6 groups: normal group,model group,HJBD high dose group,mid dose group,and low dose group( 6. 84,13. 68,27. 36 g·kg- 1),as well as Qianggan tablets group( 0. 067 g·kg- 1). All other groups except the normal group were given with high-fat diet for 8 weeks,and then the rats were either treated with low,middle or high doses of HJBD and Qianggan tablets through gastric gavage for 10 weeks. Fast serum samples were obtained for lipid profile. Liver histopathogy was performed on HE slides,and the expressions levels of MTP mRNA and protein in liver tissues were assayed by Real-time PCR. Result: Immunohistochemistry and RT-PCR results showed that,compared with the normal group,MTP expression was decreased in model group,with statistically significant difference( P 〈 0. 01).Compared with the model group,the expression levels of MTP were increased in various dose groups of HJBD and Qianggan tablets group,with statistically significant difference( P 〈 0. 01,P〈 0. 05),especially in high dose group. Blood lipids metabolic disorder and liver steatosis were also improved to varying degrees in the treatment groups as compared with the model group. Conclusion: HJBD has a good therapeutic effect for NAFLD rats induced by high-fat diet,and we speculate that MTP mRNA may be its effective targets.
出处 《中国实验方剂学杂志》 CAS CSCD 北大核心 2016年第6期109-113,共5页 Chinese Journal of Experimental Traditional Medical Formulae
基金 广西壮族自治区自然科学基金项目(2014GXNSFBA402001)
关键词 非酒精性脂肪肝病 活血降脂保肝汤 微粒体甘油三脂转运蛋白 non-alcoholic fatty liver disease Huoxue Jiangzhi Baogan decoction microsomal triglyceride transfer protein
  • 相关文献

参考文献10

  • 1Day C P. Non-alcoholic fatty liver disease: a massive problem[J]. Clin Med(Lond) ,2011, 11(2):176-178.
  • 2范建高.非酒精性脂肪性肝病诊疗指南(2010年修订版)[J].胃肠病学和肝病学杂志,2010,19(6):483-487. 被引量:409
  • 3王倩,管小琴.大鼠非酒精性脂肪肝造模方法的改进[J].世界华人消化杂志,2007,15(11):1219-1224. 被引量:68
  • 4张林杉,高鑫.微粒体甘油三酯转运蛋白与非酒精性脂肪性肝病的研究进展[J].中华内分泌代谢杂志,2014,30(1):76-78. 被引量:5
  • 5Wetterau J R, Lin M C, Jamil H. Microsomal triglyceride transfer protein[ J]. Biochim Biophys Acta, 1997,1345(2) :136-150.
  • 6Raval S K, Raval P S, Jain M R. Emerging therapies for dyslipidemia: known knowns and known unknowns of MTP inhibitors[ J]. Recent Pat Endocr Metab Immune Drug Discov,2012,6( 1 ) :24-29.
  • 7Chang X, Yan H, Fei J, et al. Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats [ J ]. Lipid Res, 2010,51 (9) :2504-2515.
  • 8Shindo N, Fujisawa T, Sugimoto K, et al. Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model[ J ]. J Hepato1,2010 ,52 :903-912.
  • 9Pan X, Hussain F N, lqbal J, et al. Inhibiting proteasomal degradation of mierosomal triglyceride transfer protein prevents CC14-induecd steatosis [ J]. J Biol Chem ,2007,282 ( 23 ) : 17078-17089.
  • 10Fabbrini E, Mohammed B S, Magkos F, et al. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease [ J ]. Gastroenterology, 2008.134 ( 2 ) :424-431.

二级参考文献31

  • 1Fan, Jian-Gao,Peng, Yong-De.Metabolic syndrome and non-alcoholic fatty liver disease:Asian definitions and Asian studies[J].Hepatobiliary & Pancreatic Diseases International,2007,6(6):572-578. 被引量:42
  • 2范建高.糖尿病与肝病的关系及其诊治对策[J].中华糖尿病杂志,2009,1(4). 被引量:30
  • 3Jian-Gao Fan Zheng-Jie Xu Guo-Liang Wang.Effect of lactulose on establishment of a rat non-alcoholic steatohepatitis model[J].World Journal of Gastroenterology,2005,11(32):5053-5056. 被引量:33
  • 4Musso G,Gambino R,Cassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)[J].{H}Progress in Lipid Research,2009.1-26.
  • 5Wetterau JR,Lin MC,Jamil H. Microsomal triglyceride transfer protein[J].{H}Biochimica et Biophysica Acta,1997.136-150.
  • 6Jamil H,Dickson JK Jr,Chu CH. Microsomal triglyceride transfer protein.Specificity of lipid binding and transport[J].{H}Journal of Biological Chemistry,1995.6549-6554.
  • 7Borradaile NM,de Dreu LE,Barrett PH. Inhibition ofhepatocyte apoB secretion by naringenin:enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters[J].{H}Journal of Lipid Research,2002.1544-1554.
  • 8Raval SK,Raval PS,Jain MR. Emerging therapies for dyslipidemia:known knowns and known unknowns of MTP inhibitors[J].Recent Pat Endocr Metab Immune Drug Discov,2012.24-29.
  • 9Cuchel M,Bloedon LT,Szapary PO. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia[J].{H}New England Journal of Medicine,2007.148-156.
  • 10Liao W,Hui TY,Young SG. Blocking microsomal triglyceride transfer protein interferes with apoB secretion without causing retention or stress in the ER[J].{H}Journal of Lipid Research,2003.978-985.

共引文献477

同被引文献81

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部